Identity
- Security key
- 21059
- Ticker
- RNAC
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2016-06-22
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- RNAC
Detail
Enriched 2026-08-14 20:47
- Market cap
- $262,465,178.6
- Shares outstanding (class)
- 30,255,352
- Shares outstanding (weighted)
- 30,255,352
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 75
- Location
- FREDERICK, MD
- Description
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.